Advertisement

Mitral Valve Replacement

  • David Blitzer
  • Jeremy J. Song
  • Damien J. LaParEmail author
Chapter
  • 13 Downloads

Abstract

The etiology of mitral valve disease is generally categorized as degenerative, ischemic, rheumatic, or infectious. Globally, rheumatic heart disease (RHD) remains a major cause of mitral valve disease. Mitral valve replacement may be performed for both mitral valve stenosis and mitral valve regurgitation due to structural or functional changes in the mitral valve apparatus. Replacement options include mechanical valves, bioprosthetic valves, and less commonly stentless valves or use of a pulmonary autograft. In general, mechanical valves offer increased durability compared to bioprosthetic valves but at the expense of an increased risk of valve thrombosis requiring long term coagulation. Transcatheter mitral valve replacement is an emerging technology for the management of mitral valve disease.

Keywords

Bioprosthetic valves Mechanical valves Mitral regurgitation Mitral stenosis Mitral valve replacement Rheumatic mitral disease 

References

  1. 1.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;70:252–89.CrossRefGoogle Scholar
  2. 2.
    Movahed MR, Ahmadi-Kashani M, Kasravi B, Saito Y. Increased prevalence of mitral stenosis in women. J Am Soc Echocardiogr. 2006;19:911–3.CrossRefGoogle Scholar
  3. 3.
    Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67–84.CrossRefGoogle Scholar
  4. 4.
    Iung B, Vahanian A. Epidemiology of acquired valvular heart disease. Can J Cardiol. 2014;30:962–70.CrossRefGoogle Scholar
  5. 5.
    Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol. 2007;32:609–61.CrossRefGoogle Scholar
  6. 6.
    Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.CrossRefGoogle Scholar
  7. 7.
    Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–94.CrossRefGoogle Scholar
  8. 8.
    Enriquez-Sarano M, Schaff HV, Orszulak TA, et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91:1022–8.CrossRefGoogle Scholar
  9. 9.
    Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23–32.CrossRefGoogle Scholar
  10. 10.
    Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152–8.CrossRefGoogle Scholar
  11. 11.
    D’Alessandro L, Narducci C, Pucci A, et al. The use of mechanical valves in the treatment of valvular heart disease. New York: Springer; 1986. p. 31.Google Scholar
  12. 12.
    Butterfield M, Fisher J, Davies GA, Spyt TJ. Comparative study of the hydrodynamic function of the CarboMedics valve. Ann Thorac Surg. 1991;52:815–20.CrossRefGoogle Scholar
  13. 13.
    David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg. 2001;121:268–77.CrossRefGoogle Scholar
  14. 14.
    Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM, Marchand MA. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg. 1998;66:143–7.CrossRefGoogle Scholar
  15. 15.
    Frater RW. Stentless mitral valves. J Thorac Cardiovasc Surg. 2007;133:861–4.CrossRefGoogle Scholar
  16. 16.
    Kabbani S, Jamil H, Nabhani F, Hamoud A, Katan K, Sabbagh N, et al. Analysis of 92 mitral pulmonary autograft replacement (Ross II) operations. J Thorac Cardiovasc Surg. 2007;134:902–8.CrossRefGoogle Scholar
  17. 17.
    LaPar DJ, Acker MA, Gelijns AC, Kron IL. Repair or replace for severe ischemic mitral regurgitation: prospective randomized multicenter data. Ann Cardiothorac Surg. 2015;4:411–6.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Chitwood WR Jr, Wixon CL, Elbeery JR, Moran JF, Chapman WH, Lust RM. Video-assisted minimally invasive mitral valve surgery. J Thorac Cardiovasc Surg. 1997;114:773–80.CrossRefGoogle Scholar
  19. 19.
    Hawkins RB, Mehaffey JH, Mullen MM, Nifong WL, Chitwood WR, Katz MR, et al., Investigators for the Virginia Cardiac Services Quality Initiative. A propensity matched analysis of robotic, minimally invasive, and conventional mitral valve surgery. Heart. 2018.  https://doi.org/10.1136/heartjnl-2018-313129. pii: heartjnl-2018-313129. [Epub ahead of print].CrossRefGoogle Scholar
  20. 20.
    Sternik L, Zehr KJ, Orszulak TA, Mullany CJ, Daly RC, Schaff HV. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis. 2002;11:91–7.Google Scholar
  21. 21.
    Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111–9.CrossRefGoogle Scholar
  22. 22.
    Brennan JM, Edwards FH, Zhao Y, O'Brien S, Booth ME, Dokholyan RS, et al. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. J Am Coll Cardiol. 2012;60:971–7.CrossRefGoogle Scholar
  23. 23.
    Ezekowitz MD. Anticoagulation management of valve replacement patients. J Heart Valve Dis. 2002;11(Suppl 1):S56–61.PubMedGoogle Scholar
  24. 24.
    Jegaden O, Eker A, Delahaye F, Montagna P, Ossette J, Durand de Gevigney G, et al. Thromboembolic risk and late survival after mitral valve replacement with the St Jude Medical valve. Ann Thorac Surg. 1994;58:1721–8.CrossRefGoogle Scholar
  25. 25.
    Bapat V, Rajagopal V, Meduri C, Farivar RS, Walton A, Duffy SJ, et al., Intrepid Global Pilot Study Investigators. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018; 71:12–21.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • David Blitzer
    • 1
  • Jeremy J. Song
    • 1
  • Damien J. LaPar
    • 1
    Email author
  1. 1.Department of Cardiothoracic SurgeryColumbia University Vagelos College of Physicians and SurgeonsNew YorkUSA

Personalised recommendations